S
52.63
0.12 (0.23%)
| Penutupan Terdahulu | 52.51 |
| Buka | 52.50 |
| Jumlah Dagangan | 3,486,838 |
| Purata Dagangan (3B) | 3,128,226 |
| Modal Pasaran | 2,721,926,144 |
| Harga / Pendapatan (P/E TTM) | 134.95 |
| Harga / Pendapatan (P/E Ke hadapan) | 9.78 |
| Harga / Jualan (P/S) | 10.87 |
| Harga / Buku (P/B) | 4.53 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 May 2026 |
| EPS Cair (TTM) | -4.74 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 22.73% |
| Nisbah Semasa (MRQ) | 19.64 |
| Aliran Tunai Operasi (OCF TTM) | -89.32 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -33.98 M |
| Pulangan Atas Aset (ROA TTM) | -52.40% |
| Pulangan Atas Ekuiti (ROE TTM) | -105.54% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Soleno Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
2.4
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 2.38 |
|
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 1.83% |
| % Dimiliki oleh Institusi | 109.24% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 110.00 (Wells Fargo, 109.01%) | Beli |
| Median | 100.00 (90.01%) | |
| Rendah | 85.00 (TD Cowen, 61.51%) | Beli |
| Purata | 98.33 (86.83%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 38.43 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Mar 2026 | 100.00 (90.01%) | Beli | 38.13 |
| 20 Jan 2026 | 120.00 (128.01%) | Beli | 43.73 | |
| Wells Fargo | 27 Feb 2026 | 110.00 (109.01%) | Beli | 39.07 |
| 20 Jan 2026 | 114.00 (116.61%) | Beli | 43.73 | |
| TD Cowen | 26 Feb 2026 | 85.00 (61.50%) | Beli | 38.09 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 29 Jan 2026 | Pengumuman | Soleno Therapeutics to Participate in Upcoming Conferences |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |